KZR vs NXPI · $53.9M cap vs P/E 29, rev $12.27B
Kezar Life Sciences Inc (KZR) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
KZR currently screens at market cap $53.9M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the KZR and NXPI stock pages for the full models.
Not investment advice.